Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
Author:
Funder
Fight Cancer Foundation
National Health and Medical Research Council
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference54 articles.
1. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic;Turesson;Mayo Clin Proc,2010
2. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005
3. Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection;Teh;Blood Rev,2014
4. Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide;Offidani;Leukemia Lymphoma,2011
5. Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations;Caravita;Eur J Haematol,2012
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients;The Lancet Infectious Diseases;2024-01
2. Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients;Leukemia;2023-12-07
3. Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2023-12
4. Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews;Annals of Hematology;2023-11-08
5. Treatment of multiple myeloma based on autologous stem cell transplant: An overview of systematic reviews;Medicine;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3